These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34379893)

  • 21. Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.
    Criado MF; Sá E Silva M; Lee DH; Salge CAL; Spackman E; Donis R; Wan XF; Swayne DE
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knowledge, attitudes and practices relating to influenza A(H7N9) risk among live poultry traders in Guangzhou City, China.
    Ma X; Liao Q; Yuan J; Liu Y; Liu Y; Chen J; Liu J; Cai W; Cowling BJ; Di B; Fielding R; Wang M; Yang Z; Leung GM; Lau EH
    BMC Infect Dis; 2014 Oct; 14():554. PubMed ID: 25324011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
    Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
    Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Avian influenza vaccination: the experience in China.
    Chen H
    Rev Sci Tech; 2009 Apr; 28(1):267-74. PubMed ID: 19618631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and biological properties of H7N9 avian influenza viruses detected after application of the H7N9 poultry vaccine in China.
    Yin X; Deng G; Zeng X; Cui P; Hou Y; Liu Y; Fang J; Pan S; Wang D; Chen X; Zhang Y; Wang X; Tian G; Li Y; Chen Y; Liu L; Suzuki Y; Guan Y; Li C; Shi J; Chen H
    PLoS Pathog; 2021 Apr; 17(4):e1009561. PubMed ID: 33905456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the movement of live broilers in Guangxi, China and implications for avian influenza control.
    Tang H; Fournié G; Li J; Zou L; Shen C; Wang Y; Cai C; Edwards J; Robertson ID; Huang B; Bruce M
    Transbound Emerg Dis; 2022 Jul; 69(4):e775-e787. PubMed ID: 34693647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses.
    Liu Q; Mena I; Ma J; Bawa B; Krammer F; Lyoo YS; Lang Y; Morozov I; Mahardika GN; Ma W; García-Sastre A; Richt JA
    J Virol; 2015 Jul; 89(14):7401-8. PubMed ID: 25926639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
    Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
    J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single Dose of Bivalent H5 and H7 Influenza Virus-Like Particle Protects Chickens Against Highly Pathogenic H5N1 and H7N9 Avian Influenza Viruses.
    Hu J; Peng P; Li J; Zhang Q; Li R; Wang X; Gu M; Hu Z; Hu S; Liu X; Jiao X; Peng D; Liu X
    Front Vet Sci; 2021; 8():774630. PubMed ID: 34859093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk assessment of the newly emerged H7N9 avian influenza viruses.
    Chang P; Sadeyen JR; Bhat S; Daines R; Hussain A; Yilmaz H; Iqbal M
    Emerg Microbes Infect; 2023 Dec; 12(1):2172965. PubMed ID: 36714929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.
    Leung HC; Chan CC; Poon VK; Zhao HJ; Cheung CY; Ng F; Huang JD; Zheng BJ
    Emerg Microbes Infect; 2015 Apr; 4(4):e22. PubMed ID: 26038770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Systematic Review of the Comparative Epidemiology of Avian and Human Influenza A H5N1 and H7N9 - Lessons and Unanswered Questions.
    Bui C; Bethmont A; Chughtai AA; Gardner L; Sarkar S; Hassan S; Seale H; MacIntyre CR
    Transbound Emerg Dis; 2016 Dec; 63(6):602-620. PubMed ID: 25644240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated Evolution of H7N9 Subtype Influenza Virus under Vaccination Pressure.
    Wu Y; Hu J; Jin X; Li X; Wang J; Zhang M; Chen J; Xie S; Qi W; Liao M; Jia W
    Virol Sin; 2021 Oct; 36(5):1124-1132. PubMed ID: 33974230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines.
    Kim SH; Samal SK
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30917500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid Evolution of H7N9 Highly Pathogenic Viruses that Emerged in China in 2017.
    Shi J; Deng G; Ma S; Zeng X; Yin X; Li M; Zhang B; Cui P; Chen Y; Yang H; Wan X; Liu L; Chen P; Jiang Y; Guan Y; Liu J; Gu W; Han S; Song Y; Liang L; Qu Z; Hou Y; Wang X; Bao H; Tian G; Li Y; Jiang L; Li C; Chen H
    Cell Host Microbe; 2018 Oct; 24(4):558-568.e7. PubMed ID: 30269969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic - China, October 1, 2016-August 7, 2017.
    Kile JC; Ren R; Liu L; Greene CM; Roguski K; Iuliano AD; Jang Y; Jones J; Thor S; Song Y; Zhou S; Trock SC; Dugan V; Wentworth DE; Levine MZ; Uyeki TM; Katz JM; Jernigan DB; Olsen SJ; Fry AM; Azziz-Baumgartner E; Davis CT
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(35):928-932. PubMed ID: 28880856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of vaccines and vaccination on global control of avian influenza.
    Swayne DE
    Avian Dis; 2012 Dec; 56(4 Suppl):818-28. PubMed ID: 23402099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A model to control the epidemic of H5N1 influenza at the source.
    Guan Y; Chen H; Li K; Riley S; Leung G; Webster R; Peiris J; Yuen K
    BMC Infect Dis; 2007 Nov; 7():132. PubMed ID: 17999754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens.
    Hu J; Liang Y; Hu Z; Wang X; Gu M; Li R; Ma C; Liu X; Hu S; Chen S; Peng D; Jiao X; Liu X
    Arch Virol; 2019 Mar; 164(3):807-817. PubMed ID: 30671655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prime-Boost Vaccination With a Novel Hemagglutinin Protein Produced in Bacteria Induces Neutralizing Antibody Responses Against H5-Subtype Influenza Viruses in Commercial Chickens.
    Sączyńska V; Romanik-Chruścielewska A; Florys K; Cecuda-Adamczewska V; Łukasiewicz N; Sokołowska I; Kęsik-Brodacka M; Płucienniczak G
    Front Immunol; 2019; 10():2006. PubMed ID: 31552018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.